RFK Jr. JRE #2461 announcement
This is one entry from the TitrateLab Vendor Graveyard, a dated, primary-source archive of peptide-market shutdowns, exit scams, and enforcement actions. Documented as February 27, 2026. Sources for this entry are named inline below and numbered in full on the parent archive page.
During episode 2461 of The Joe Rogan Experience, HHS Secretary Robert F. Kennedy Jr. announced that approximately 14 of the 19 Category 2-restricted peptides would return to Category 1, restoring legal 503A access to BPC-157, TB-500, CJC-1295, Ipamorelin, AOD-9604, GHK-Cu, Selank, Semax, KPV, MOTS-C, Thymosin Alpha-1, and others under physician prescription.
Why it still matters: single-handedly removed the core policy driver of the grey market for ~14 compounds. Peptide Sciences’ shutdown announcement came 8 days later. The formal step in the reversal is the PCAC consultation scheduled for July 23, 2026. We cover the forward impact in our MAHA / PCAC preview piece.